DRUG SAFETY RESEARCH UNIT
Updates & Highlights
Samjin files IND for phase 1 trial of MRGPRX2 inhibitor SJN314, eyes global partnerships
Samjin files IND for phase 1 trial of MRGPRX2 inhibitor SJN314, eyes global partnerships - Read more on koreabiomed.com
koreabiomed.com · about 2 months ago
newsGP - TGA issues weight-loss drug safety alerts
newsGP - TGA issues weight-loss drug safety alerts - Read more on Royal Australian College of General Practitioners (...
Royal Australian College of General Practitioners (RACGP) · 4 months ago
HKUMed leads in synergising global clinical trials data: Reviewing cardiovascular drug safety and novel clinical applications - All News - Media
HKUMed leads in synergising global clinical trials data: Reviewing cardiovascular drug safety and novel clinical appl...
The University of Hong Kong (HKU) · 2 months ago
Recent Openings
View all 1 jobsCulture & Mission
Benefits & Perks
Competitive Salary
Market-rate compensation
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
401(k) Match
Retirement savings
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Team information coming soon